<unk>  (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990.
Altretamine
Ergotamine
Ebastine
Orciprenaline
Clemastine
Isoprenaline
Hexoprenaline
Eluxadoline